Autoimmune Hepatitis-Induced by Drugs: a Challenging Diagnosis Einar S. Björnsson Drug-Induced Liver Injury (F Bessone and R Andrade, Section Editors) 25 October 2017 Pages: 265 - 270
Biochemical and Molecular Mechanisms of Liver Damage-Induced by Antidepressant Drugs: an Update Review Ayantika PalDijendra Nath Roy Drug-Induced Liver Injury (F Bessone and R Andrade, Section Editors) 19 October 2017 Pages: 271 - 275
Acute Liver Failure Induced by Anti-infectious Drugs: Causes and Management Harshad Devarbhavi Drug-Induced Liver Injury (F Bessone and R Andrade, Section Editors) 23 October 2017 Pages: 276 - 285
Hepatotoxicity in Patients with Metabolic Syndrome: Causes and Consequences Jose Ignacio VargasJuan Pablo ArabMarco Arrese Drug-Induced Liver Injury (F Bessone and R Andrade, Section Editors) 24 October 2017 Pages: 286 - 292
Hepatotoxicity of New Antitumor Agents Nelia Hernandez Drug-Induced Liver Injury (F Bessone and R Andrade, Section Editors) 07 November 2017 Pages: 293 - 297
Imaging-Based Assessment of Steatosis, Inflammation and Fibrosis in NAFLD Timothy HardyStuart McPherson Fatty Liver Disease (S Harrison and J George, Section Editors) Open access 16 November 2017 Pages: 298 - 307
Wet Biomarker-Based Assessment of Steatosis, Inflammation, and Fibrosis in NAFLD Peter Lykke EriksenKaren Louise ThomsenHenning Grønbæk Fatty Liver Disease (S Harrison and J George, Section Editors) 24 October 2017 Pages: 308 - 316
Recent Advances in the Pathogenesis of Hepatitis C Virus-Related Non-Alcoholic Fatty Liver Disease and Its Impact on Patients Cured of Hepatitis C Takumi KawaguchiHironori KogaTakuji Torimura Fatty Liver Disease (S Harrison and J George, Section Editors) 19 October 2017 Pages: 317 - 325
Managing the Burden of Non-NASH NAFLD Christopher J. DanfordJorge E. SanchezKathleen E. Corey Fatty Liver Disease (S Harrison and J George, Section Editors) 27 October 2017 Pages: 326 - 334
Genetic and Epigenetic Associations of NAFLD: Focus on Clinical Decision Making Mayada MetwallyMohammed EslamJacob George Fatty Liver Disease (S Harrison and J George, Section Editors) 07 November 2017 Pages: 335 - 345
What Is the Optimal Dietary Composition for NAFLD? Elena S. GeorgeAudrey C. TierneyIngrid J. Hickman Fatty Liver Disease (S Harrison and J George, Section Editors) 25 October 2017 Pages: 346 - 355
Role of Exercise in NAFLD/NASH: What is the Right Prescription? Luis Calzadilla BertotLeon Anton Adams Fatty Liver Disease (S Harrison and J George, Section Editors) 27 October 2017 Pages: 356 - 365
Overview of Clinical Treatment Trials for NASH Monica A. KonermanStephen A. Harrison Fatty Liver Disease (S Harrison and J George, Section Editors) 23 October 2017 Pages: 366 - 373
Managing HCC in NAFLD Darren Hiu-Sun FoogDeborah KwokVincent Wai-Sun Wong Fatty Liver Disease (S Harrison and J George, Section Editors) 19 October 2017 Pages: 374 - 381
Non-alcoholic Fatty Liver Disease in Non-obese Patients Christopher J. SchmoyerMohammad S. Siddiqui Fatty Liver Disease (S Harrison and J George, Section Editors) 23 October 2017 Pages: 382 - 390
Natural History of NAFLD/NASH Mattias EkstedtPatrik NasrStergios Kechagias Fatty Liver Disease (S Harrison and J George, Section Editors) Open access 13 November 2017 Pages: 391 - 397
Endoscopic Therapy for Variceal Bleeding: from Patient Preparation to Available Techniques and Rescue Therapies Philippe SultanikDominique Thabut Portal Hypertension (E Tsochatzis and J Abraldes, Section Editors) 23 October 2017 Pages: 398 - 405
The Management of Bleeding from Anorectal Varices Marcus RobertsonAlexandra Ines ThompsonPeter Clive Hayes Portal Hypertension (E Tsochatzis and J Abraldes, Section Editors) Open access 07 November 2017 Pages: 406 - 415